Exposure to the Psychedelic Substance 25H-NBOMe Disrupts Maternal Care in Lactating Rats and Subsequently Impairs the Social Play Behavior of the Offspring.
Larissa M.a. Melo, Wellington A De Barros, Ângelo de Fátima, F. C. V. Giusti, Alexandre Giusti-Paiva
Behavioural Brain Research February 1, 2024 DOI: 10.1016/j.bbr.2024.114924 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Controlled experiment Peer reviewed |
|---|---|
| Population | Lactating rats and their offspring |
| Intervention | 25H-NBOMe |
| Dose | 0.3mg/kg and 1.0mg/kg |
| Key findings | 25H-NBOMe significantly disrupts maternal behaviors and reduces offspring social play, with effects occurring even at doses that do not visibly alter maternal behavior. |
Abstract
Given the critical role of maternal care in the neurodevelopment of offspring, this study aimed to investigate the effects of the psychedelic substance 25H-NBOMe on maternal behavior in lactating rats and its subsequent impact on the social and neurodevelopmental behavior of the offspring. We administered two different dosages of 25H-NBOMe (0.3mg/kg and 1.0mg/kg; i,p,) to lactating rats and observed changes in maternal behaviors, such as nest-building and pup retrieval, and in offspring behaviors, including social play. Behavioral assessments were complemented by physiological measurements to rule out general health or nutritional decline. 25H-NBOMe significantly disrupted maternal behaviors, including nest-building and pup retrieval, without affecting the weight of dams or offspring. Offspring of exposed dams exhibited reduced social play behavior. Higher doses led to more pronounced disruptions, while lower doses, despite not visibly affecting maternal behavior, still impacted offspring behavior, suggesting potential direct effects of 25H-NBOMe. The study highlights the potential risks associated with the use of 25H-NBOMe during lactation, emphasizing its detrimental impact on maternal care and offspring development. These findings contribute to understanding the neurobiological effects of psychedelic substances during critical developmental periods and underscore the importance of avoiding their use.
Citations in the library
Cited by 3
- Psychedelic 25H-NBOMe attenuates post-sepsis depression in rats. Neuroscience Letters June 21, 2024
- Psilocybin during the postpartum period induces long-lasting adverse effects in both mothers and offspring Nature Communications September 30, 2025
- Psychedelic Drugs Rediscovered-In Silico Study of Potential Fetal Exposure to Analogues of Psychedelic Drugs During Pregnancy. Molecules January 8, 2026
Cites 11
- Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens. Current Topics in Behavioral Neurosciences 2017
- Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice. Naunyn-Schmiedeberg's Archives of Pharmacology May 1, 2024
- The Effects of Psychedelics on Neuronal Physiology. Annu Rev Physiol November 6, 2023
- Psychedelics action and schizophrenia. Pharmacological Reports October 30, 2023
- Neurotoxicological profile of the hallucinogenic compound 25I-NBOMe. Scientific Reports February 21, 2022
and 6 more in the library